• Media type: E-Article
  • Title: Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model
  • Contributor: Lepak, Alexander J.; Zhao, Miao; Andes, David R.
  • imprint: American Society for Microbiology, 2018
  • Published in: Antimicrobial Agents and Chemotherapy
  • Language: English
  • DOI: 10.1128/aac.01572-18
  • ISSN: 0066-4804; 1098-6596
  • Origination:
  • Footnote:
  • Description: <jats:p> Rezafungin (CD101) is a novel echinocandin under development for once-weekly intravenous (i.v.) dosing. We evaluated the pharmacodynamics (PD) of rezafungin against 4 <jats:named-content content-type="genus-species">Candida auris</jats:named-content> strains, using the neutropenic mouse invasive candidiasis model. </jats:p>
  • Access State: Open Access